537.30
+4.06%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Dr. Agarwal's Health Care
Its shares trade on NSE under the ticker AGARWALEYE.NS. It has been listed since 4 February 2025. In the fiscal year to 31 March 2026, it reported revenue of ₹20.80bn and net income of ₹1.33bn. At that date it held total assets of ₹39.42bn and shareholders' equity of ₹20.25bn.
Dr. Agarwal's Health Care Ltd is a IN-based company operating in industry. The company is headquartered in Chennai, Tamil Nadu. The company went IPO on 2025-02-04. Dr. Agarwal's Health Care Ltd is an India-based company, which operates as a health care institution. The firm is engaged in running, owning and managing eye care hospitals, optical, pharmacies, etc. and related services. The company provides a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sells optical, contact lenses and accessories, and eye-care related pharmaceutical products. Its services include surgeries and consultations, diagnoses and non-surgical treatments. Its surgery services include cataract surgery, refractive surgery, and other surgery. Its consultations, diagnoses and non-surgical treatments offer doctor consultation services, diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment. The company provides a range of glasses, lenses, contact lenses and frames at its facilities.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 4 Feb 2025
- Website
- dragarwal.com ↗
Leadership
Pay as last reported
- Dr. Amar AgarwalNon-Executive Chairman of the Board
- Dr. Adil AgarwalWhole Time Director, Chief Executive Officer, since 2010₹48.7m
- Mr. Yashwanth VenkatChief Financial Officer₹5.2m
- Dr. Anosh AgarwalWhole Time Director, Chief Operating Officer, since 2014₹49.2m
- Mr. Thanikainathan ArumugamVice President - Corporate Affairs, Company Secretary, Compliance Officer₹6.9m
- Mr. Ved KalanoriaNon-Executive Nominee Director
- Mr. Ankur ThadaniNon-Executive Nominee Director
- Mr. Sanjay AnandNon-Executive Independent Director₹200,000
- Mr. Venkatraman BalakrishnanNon-Executive Independent Director₹180,000
- Ms. Archana BhaskarNon-Executive Independent Director
- Mr. Nachiket MorNon-Executive Independent Director
- Dr. Ranjan PaiNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Dr. Agarwal's Health Care Ltd operates eye care hospitals in Chennai, Tamil Nadu, India.
- The company provides comprehensive eye care services including cataract and refractive surgeries.
- Dr. Agarwal's Health Care Ltd sells optical products and pharmaceuticals at its facilities.
Weaknesses
- The company's services are limited to eye care without broader health care offerings.
- Dr. Agarwal's Health Care Ltd has no presence in other Indian cities beyond Chennai.
- The company's IPO listing date is 4 February 2025, which may affect early market perception.
Opportunities
- Expanding eye care services to other Indian cities like Mumbai and Delhi.
- Increasing sales of optical products and pharmaceuticals through online channels.
- Growing demand for eye care services in India's aging population.
Threats
- Competition from other eye care providers in Chennai, India.
- Rising costs of medical equipment affecting profit margins.
- Regulatory changes in India's health care sector impacting operations.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.